Opening Lecture

Wednesday October 10th | 18:30 – 19:30

Michael Oellerich

Michael Oellerich

Laboratory medicine – challenges and opportunities

CV | SUMMARY

Diagnostic approach to hemostasis disorders

Thursday October 11th | 09:00 – 10:30

Sophie Testa

Sophie Testa

Coagulation testing and new oral anticoagulants

CV | SUMMARY  

  

Tilman Hackeng

Tilman Hackeng

Biomarkers of hemostasis and thrombosis

CV  | SUMMARY

Hugo ten Cate

Hugo ten Cate

Diagnostic approach to hemostasis disorders

CV  | SUMMARY

Laboratory testing guideline in the intensive care unit

Thursday October 11th | 09:00 – 10:30

Ismail Cinel

The role of laboratory medicine in intensive care unit

Michael Meisner

Michael Meisner

Inflammation versus sepsis: Focus on biomarkers

CV | SUMMARY  

Paul M. Tulkens

Paul M. Tulkens

TDM of antibiotics

CV | SUMMARY  

Plenary Lecture

Thursday October 11th | 10:45-11:30

Michael Neumaier

Michael Neumaier

Liquid biopsy for cancer screening

CV | SUMMARY

WASPALM Symposium

Thursday October 11th | 13:00 – 14:30

Cinzia Marchese

Cinzia Marchese

Perspectives on women’s health care: Novel approaches for rare diseases, aging and cancer

CV | SUMMARY 

Mariano Bizzarri

Mariano Bizzarri

Inositol metabolites as biomarkers of peripheral complications in insulin resistant and diabetes patients

Elisabetta Stenner

Elisabetta Stenner

Usefulness of intraoperative parathyroid hormone monitoring during minimally invasive video-assisted parathyroidectomy

Detecting kidney disease: From proteomics to the clinical laboratory

Thursday October 11th | 13:00 – 14:30

Elisabetta Verderio Edwards

Urinary exosomes as a novel source of biomarkers of kidney disease

Halide Akbas

Halide Akbas

Urinary biomarkers in kidney transplantation: Application of Mass Spectrometry to measure peptides and proteins

CV | SUMMARY  

Edmund J. Lamb

Edmund J. Lamb

The clinical laboratory and kidney disease

CV | SUMMARY  

Pediatric laboratory medicine

Thursday October 11th | 14:45-16:15

Juergen Okun

Newborn screening for metabolic and lysosomal diseases

Luis Masana

The role of laboratory in diagnosis and management of familial hypercholesterolemia

The utility of biomarkers in neurological disorders

Thursday October 11th | 14:45-16:15

Sylvain Lehmann

The diagnosis and managemet of demantia

Medical guidelines and clinical decision making

Thursday October 11th | 14:45-16:15

Michel Langlois

Michel Langlois

Medical guidelines may not always be compatible with laboratory practice

CV | SUMMARY  

Wytze Oosterhuis

Wytze Oosterhuis

Laboratory and clinical cooperation in enhancing clinical decision making

CV | SUMMARY  

Ana Maria Simundic

Ana Maria Simundic

Demand management (test utilization)

CV | SUMMARY  

Endocrinologist and laboratorian, a friendship under construction

Thursday October 11th | 16:30 – 17:30

Ilhan Satman

What do the endocrinologists expect from laboratory?

Howard Morris

Howard Morris

The role of laboratory in metabolic bone disease

CV | SUMMARY  

The rise and fall of total error concept in laboratory medicine

Thursday October 11th | 16:30 – 17:30

Anders Kallner

Anders Kallner

Uncertainty or total allowable error: The big debate

CV | SUMMARY  

Elvar Theodorsson

Elvar Theodorsson

From measurement to diagnosis: Uncertainty in laboratory medicine

CV | SUMMARY  

HbA1c will remain the preferred marker for assessing glycaemic control

Thursday October 11th | 17:30-18:30

Garry John

Garry John

CV | SUMMARY  

Eric Kilpatrick

Eric Kilpatrick

CV | SUMMARY  

A harmonised approach to generating and applying biological variation data

Friday October 12th | 09:00 – 10:30

Sverre Sandberg

Sverre Sandberg

Biological variation, from theory to practice. The projects of EFLM

CV | SUMMARY  

Anna Carobene

Anna Carobene

European Biological Variation Study (EuBIVAS): Sample collections from healthy volunteers from six European Labs for biological variation estimates’ update

CV | SUMMARY  

Abdurrahman Coskun

Abdurrahman Coskun

Biological variation of CBC tests: The effect of turnarround time

CV | SUMMARY  

Role of Gut microbiota in metabolism and inflammatory bowel diseases

Friday October 12th | 09:00 – 10:30

Ahmet Uygun

Gut microbiota and its relationship with obesity, metabolic syndrome and diabetes

Jurgen Stein

Celiac disease antibody testing: New trends in diagnosis, guidelines and new markers

Murat Toruner

Faecal biomarkers in diagnosis and monitoring of inflammatory bowel disease

Plenary Lecture

Friday October 12th  |  10:45-11:30

Nurdan Tözün

The Liver: Maestro of metabolism

IATDMCT Symposium

Friday October 12th | 13:00 – 14:30

Katharina Rentsch

The future of LC-MS/MS in forensic laboratory and clinical toxicology

Eberhard Wieland

Eberhard Wieland

Therapeutic drug monitoring in transplant patients

CV | SUMMARY  

Erik van Maarseveen

Therapeutic drug monitoring for anti-hypertensive drugs

Harmonisation of training and continuing professional development in laboratory medicine

Friday October 12th | 13:00 – 14:30

Thomas Zima

Thomas Zima

Curricula of laboratory medicine in medical schools

CV | SUMMARY  

Pinar Tuncel

Standardization of education of specialists on medical biochemistry in Turkey

Matthias Orth

Matthias Orth

Education of specialists on laboratory medicine in EU

CV | SUMMARY  

Strategic role of laboratory management and leadership in clinical outcome

Friday October 12th | 15:25 – 16:25

Roberto Verna

Roberto Verna

The role of laboratory specialist in clinical diagnostic team

CV | SUMMARY  

Fatma Taneli

Fatma Taneli

Laboratory medicine in the new regulatory and healthcare environment: From essentialism to consequentialism

CV | SUMMARY  

The role of clinical laboratories in diagnosis and manegement of cancer

Friday October 12th | 15:25 – 16:25

Aldo Tomasi

Aldo Tomasi

The role of laboratory in determination and management of anticancer therapies

CV | SUMMARY  

Brent L. Wood

Brent L. Wood

The impact of flow cytometry in clinical laboratory

CV | SUMMARY  

Autoimmunity, allergic disorders and immunodeficiency

Friday October 12th | 16:40-18:10

Joanna Sheldon

The role of the laboratory in diagnosis and management of autoimmune disease

Ravishankar Sargur

Ravishankar Sargur

The role of the laboratory in the diagnosis and management of allergic disease

CV | SUMMARY  

Kimberly Gilmour

Kimberly Gilmour

The role of the immunology laboratory in the diagnosis and management of primary immune deficiency

CV | SUMMARY  

Personalized medicine

Friday October 12th | 16:40-17:40

Mario Pazzagli

The role of laboratory medicine in personalized and precision medicine

Yesim Ozarda

Yesim Ozarda

Personalized reference intervals

CV | SUMMARY  

Patient safety and ethical issues in laboratory medicine

Saturday October 13th | 09:00- 10:30

Mario Plebani

Risk management in clinical laboratory and patient safety

Mustafa Serteser

Improvement of laboratory test value by evidence based strategies

John Harris

Ethical issues in laboratory medicine

Smart technologies in the diagnosis and monitoring of patients

Saturday October 13th | 09:00- 10:30

Yildiz Uludag

Lab-on-a-chip technology for clinical diagnostics

Dobrin Svinarov

Dobrin Svinarov

Enhancing precision medicine through clinical mass spectrometry platform

CV | SUMMARY  

Ahmet Tarik Baykal

MALDI imaging in clinical laboratories

PLENARY LECTURE

Saturday October 13th  |  10:45 – 11:30

George Lundberg

George Lundberg

Patient focused Laboratory Medicine

Diet, inflammation and atherosclerosis

Saturday October 13th | 11:45- 12:45

Burcu Barutcuoglu

Burcu Barutcuoglu

Vascular inflammation and atherosclerosis

CV | SUMMARY  

Matthias Nauck

Matthias Nauck

Metabolomics and cardiovascular disease

CV | SUMMARY  

Biomarkers of heart failure and prognosis

Saturday October 13th | 11:45- 12:45

Jordi Ordonez Llanos

The utility of high sensitive troponins in early diagnosis or rule out of AMI

Mehmet Birhan Yilmaz

Mehmet Birhan Yilmaz

Prognostic markers of heart failure